Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1998-02-24
2000-12-12
Wortman, Donna C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C12Q 170
Patent
active
061599395
ABSTRACT:
Viral morphogenesis, production, release or uncoating can be inhibited by effecting inhibition of prenylation of, or inhibition of post-prenylation reactions of, at least one viral protein. The use of inhibitors of prenylation, and post-prenylation reactions, for example, inhibitors of the mevalonate and prenyl group synthesis pathways, inhibitors of prenyl group transferases and mimics of the prenylation target CXXX box are disclosed.
REFERENCES:
patent: H1345 (1994-08-01), Biller
Stedman's Medical Dictionary, 24th ed., Williams & Wilkens, Baltimore, p. 889, 1982.
Hoffman M., Science (1991) 254:650-651.
Gibbs J., Cell (1991) 65:1-4.
Beck L., et al., Journal of Cell Biology (1988) 107:1307-1316.
Bruss V et al., Journal of Virology (1991) 65(7):3813-3820.
Glenn J. et al., Journal of Virology (1991) 65(5):2357-2361.
Glenn J. et al., Science (1992) 256:1331-1333.
Koff, T., Gastroenteroology (1992) 103:1978-1986; Prenylation of the large hepatitis delta virus antigen: A target for antiviral therapy.
Overmeyer et al., J. Biol. Chem. (1992) 267(31)22686-22692; Isopernoid requirement for intracellular transport and processing of murine leukemia virus envelope protein.
Glomset J., et al., TIBS Reviews (1990) pp. 139-142.
Maltese W., FASEB Journal (1990) 4:3319-3328.
Moores S. et al., The Journal of Biological Chemistry (1991) 266(22):14603-14610.
Reiss Y. et al., The Cell (1990) 62:81-88.
Schafer W. et al., Science (1989) 245:379-385.
Wang C. et al., Journal of Virology (1991)65:6630-6636.
Rightsel et al., Nature (1964) 204:1333-1334.
Van der Pyl et al., J. Antibiotics (1992) 45:1802-1805.
Detroy et al., J. Gen. Micro. (1975)92:167-174.
Miura et al., FEBS Letters (1993) 318:88-90.
Kestler, H.W. III, et al.; Importance of the nef Gene for Maintenance of High Virus Loads and for Development of AIDS; Cell (1991) 65:651-662.
Hancock et al., Cell 57:1167-1177, 1989.
Hruby et al., Abs. of Am. Soc, for Microbio., 92nd Mtg.: 400., May 1992.
Derwent Pub. Ltd., London.: Database WPI; Sec. Ch, Week 9430, Feb. 1, 1996.
Brumback Brenda G.
Wortman Donna C.
LandOfFree
Method for inhibition of viral morphogenesis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for inhibition of viral morphogenesis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for inhibition of viral morphogenesis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-217077